Narae Nanotech Corporation (KOSDAQ:137080)
South Korea · Delayed Price · Currency is KRW 6,430.00
-410.00 (-5.99%)
At close: Aug 24, 2026
Narae Nanotech Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | - | - | 0 | - | - | -0 |
| 63,924 | 54,497 | 40,426 | 52,926 | 88,040 | 135,153 | |
Revenue Growth | 11.52% | 34.81% | -23.62% | -39.88% | -34.86% | 63.22% |
Cost of Revenue | 48,678 | 49,635 | 46,851 | 56,326 | 75,808 | 100,546 |
Gross Profit | 15,245 | 4,862 | -6,425 | -3,401 | 12,232 | 34,607 |
Selling, General & Admin | 7,394 | 6,938 | 9,152 | 8,889 | 9,370 | 10,716 |
Research & Development | 4,462 | 3,923 | 4,413 | - | - | - |
Amortization of Goodwill & Intangibles | 214.18 | 216.57 | 191.23 | 170.34 | 140.88 | 113.86 |
Other Operating Expenses | 63.32 | 89.55 | 90.77 | 79.79 | 91.31 | 129.85 |
Operating Expenses | 13,442 | 13,866 | 15,700 | 11,590 | 10,276 | 11,483 |
Operating Income | 1,803 | -9,004 | -22,125 | -14,991 | 1,956 | 23,123 |
Interest Expense | -1,573 | -3,007 | -3,356 | -2,750 | -1,351 | -1,309 |
Interest & Investment Income | 405.39 | 105.58 | 209.43 | 277.74 | 231.52 | 21.45 |
Currency Exchange Gain (Loss) | 2,132 | -958.94 | 3,946 | 350.73 | 691.56 | 483.48 |
Other Non Operating Income (Expenses) | -16.1 | 6.08 | -87.19 | 63.21 | 212 | 96.9 |
EBT Excluding Unusual Items | 2,753 | -12,858 | -21,413 | -17,050 | 1,740 | 22,416 |
Gain (Loss) on Sale of Investments | 3.02 | 3.69 | 3.59 | 368.28 | 7.48 | 8.23 |
Gain (Loss) on Sale of Assets | 77,989 | 62,965 | 27.68 | -8.33 | 161.81 | 30.05 |
Asset Writedown | - | - | - | - | 751.63 | - |
Pretax Income | 80,745 | 50,111 | -21,382 | -16,690 | 2,661 | 22,454 |
Income Tax Expense | 16,569 | 10,149 | -4,240 | -3,406 | 138.9 | 4,982 |
Net Income | 64,176 | 39,961 | -17,141 | -13,283 | 2,522 | 17,472 |
Net Income to Common | 64,176 | 39,961 | -17,141 | -13,283 | 2,522 | 17,472 |
Net Income Growth | - | - | - | - | -85.57% | 682.56% |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 8 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 8 |
Shares Change | -0.63% | 0.01% | -0.01% | 1.82% | 29.43% | - |
EPS (Basic) | 5837.94 | 3613.31 | -1550.00 | -1201.10 | 232.18 | 2081.91 |
EPS (Diluted) | 5837.94 | 3613.31 | -1550.00 | -1201.10 | 232.00 | 2081.91 |
EPS Growth | - | - | - | - | -88.86% | 682.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 12,537 | 13,503 | -17,308 | -31,449 | -35,831 | 14,661 |
Free Cash Flow Per Share | 1140.49 | 1220.96 | -1565.07 | -2843.63 | -3298.70 | 1746.93 |
Dividend Per Share | - | - | - | - | 100.000 | 200.000 |
Dividend Growth | - | - | - | - | -50.00% | - |
Gross Margin | 23.85% | 8.92% | -15.89% | -6.43% | 13.89% | 25.61% |
Operating Margin | 2.82% | -16.52% | -54.73% | -28.32% | 2.22% | 17.11% |
Profit Margin | 100.39% | 73.33% | -42.40% | -25.10% | 2.86% | 12.93% |
Free Cash Flow Margin | 19.61% | 24.78% | -42.81% | -59.42% | -40.70% | 10.85% |
EBITDA | 6,944 | -3,790 | -16,786 | -10,063 | 4,581 | 25,495 |
EBITDA Margin | 10.86% | -6.95% | -41.52% | -19.01% | 5.20% | 18.86% |
D&A For EBITDA | 5,141 | 5,214 | 5,339 | 4,928 | 2,625 | 2,372 |
EBIT | 1,803 | -9,004 | -22,125 | -14,991 | 1,956 | 23,123 |
EBIT Margin | 2.82% | -16.52% | -54.73% | -28.32% | 2.22% | 17.11% |
Effective Tax Rate | 20.52% | 20.25% | - | - | 5.22% | 22.19% |
Advertising Expenses | - | 4.2 | 53.77 | 7.13 | 14.09 | 1.01 |